The proposed multidisciplinary study will examine the clinical, virologic and immunologic characteristics of acute hepatitis C virus (HCV) infection among street-recruited injection drug users (IDUs). A cohort of 100 HCV-uninfected IDUs will be followed prospectively. A highly sensitive transcription-mediated-amplification (TMA) assay will be used to detect HCV RNA in biweekly plasma specimens. Based on the HCV incidence rates we have observed in the study community, we estimate that we will observe as many as 70 new infections. Clinical, virologic, and immunologic studies of these infections will be conducted in concert, to characterize primary HCV infections among IDUs, and to assess clinical, immunologic, and virologic characteristics associated with successful immune responses and viral clearance, The aims of the proposed study are to: (1) describe the natural history of acute HCV infection in street-recruited, active IDUs by prospectively observing the spectrum of clinical and laboratory features, the viral kinetics of early infection, the proportion who spontaneously clear infection, and the timing of clearance; (2) characterize the evolution of HCV-specific cellular immune responses in acute HCV infection, including the HCV epitope specificity, precursor frequency, phenotype, cytokine profile, proliferation and cytotoxicity of HCV-specific T-cells; and (3) study the kinetics and function of HCV-specific cellular immune responses in parallel with the virologic events, comparing IDUs whose infection is cleared with those who progress to chronic infection, to determine the characteristics of a successful immune response to HCV.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA016159-05
Application #
7452424
Study Section
AIDS Clinical Studies and Epidemiology Study Section (ACE)
Program Officer
Comolli, Jean C
Project Start
2004-07-01
Project End
2009-11-30
Budget Start
2008-06-01
Budget End
2009-11-30
Support Year
5
Fiscal Year
2008
Total Cost
$400,039
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Type
Schools of Medicine
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065
Huang, Hailiang; Duggal, Priya; Thio, Chloe L et al. (2017) Fine-mapping of genetic loci driving spontaneous clearance of hepatitis C virus infection. Sci Rep 7:15843
Moroz, Ekaterina; Albrecht, Randy A; Aden, Brandon et al. (2016) Active opioid use does not attenuate the humoral responses to inactivated influenza vaccine. Vaccine 34:1363-9
Vergara, Candelaria; Thio, Chloe L; Thomas, David et al. (2016) Polymorphisms in melanoma differentiation-associated gene 5 are not associated with clearance of hepatitis C virus in a European American population. Hepatology 63:1061-2
Edlin, Brian R; Eckhardt, Benjamin J; Shu, Marla A et al. (2015) Toward a more accurate estimate of the prevalence of hepatitis C in the United States. Hepatology 62:1353-63
O'Brien, Thomas R; Pfeiffer, Ruth M; Paquin, Ashley et al. (2015) Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance. J Hepatol 63:1103-10
Edlin, Brian R; Winkelstein, Emily R (2014) Can hepatitis C be eradicated in the United States? Antiviral Res 110:79-93
Prokunina-Olsson, Ludmila; Muchmore, Brian; Tang, Wei et al. (2013) A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 45:164-71
Duggal, Priya; Thio, Chloe L; Wojcik, Genevieve L et al. (2013) Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med 158:235-45
Edlin, Brian R (2013) Hepatitis C screening: getting it right. Hepatology 57:1644-50
Uccellini, Lorenzo; Tseng, Fan-Chen; Monaco, Alessandro et al. (2012) HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations. Hepatology 56:86-94

Showing the most recent 10 out of 29 publications